Author:
Zhang Panliang,Wang Wanru,Dai Guilin,Wang Shichuan,Xu Weifeng,Tang Kewen
Funder
National Natural Science Foundation of China
Hunan Provincial Natural Science Foundation of China
Subject
Applied Microbiology and Biotechnology,Biochemistry,Bioengineering
Reference37 articles.
1. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure;Frohlich;Clin. Res. Cardiol.,2017
2. A fixed-dose combination of bisoprolol and amlodipine for hypertension: a potential benefit to selected patients;Cohen;Clin. Pharm. Drug Dev.,2017
3. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial;Williams;Lancet,2015
4. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension;de Man;Circulation,2012
5. Effects of celiprolol and bisoprolol on blood pressure, vascular stiffness, and baroreflex sensitivity;Eguchi;Am. J. Hypertens.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献